Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FIGO/ICM guidelines for preventing Rhesus disease: A call to action.

Literature DB >> 33128246

FIGO/ICM guidelines for preventing Rhesus disease: A call to action.

Gerard H A Visser^1,2, Trude Thommesen^2,3, Gian Carlo Di Renzo², Anwar H Nassar¹, Steven L Spitalnik².

Abstract

The introduction of anti-Rh(D) immunoglobulin more than 50 years ago has resulted in only a 50% decrease in Rhesus disease globally owing to a low uptake of this prophylactic approach. The International Federation of Gynecology and Obstetrics, International Confederation of Midwives, and Worldwide Initiative for Rhesus Disease Eradication have reviewed current evidence regarding the utility of anti-Rh(D) immunoglobulin. Taking into account the effectiveness anti-Rh(D), the new guidelines propose adjusting the dose for different indications and prioritizing its administration by indication.

Entities: Disease Gene Species

Keywords: Anti-D immunoglobulin; FIGO; Guidelines; International Confederation of Midwives; Prophylaxis; Rhesus disease; Worldwide Initiative for Rhesus Disease Eradication

Mesh：

Substances：

Year: 2021 PMID： 33128246 PMCID： PMC7898700 DOI： 10.1002/ijgo.13459

Source DB: PubMed Journal: Int J Gynaecol Obstet ISSN： 0020-7292 Impact factor: 3.561

21 in total

1. Feto-maternal haemorrhage following successful and unsuccessful attempts at external cephalic version.

Authors: R G Marcus; H Crewe-Brown; S Krawitz; J Katz
Journal: Br J Obstet Gynaecol Date: 1975-07

2. Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.

Authors:
Journal: Obstet Gynecol Date: 2017-08 Impact factor: 7.661

3. Single dose v two-dose antenatal anti-D prophylaxis: a randomised controlled trial.

Authors: Scott W White; Janice C Cheng; Blagica Penova-Veselinovic; Carol Wang; Melanie White; Bernie Ingleby; Christine Arnold; Craig E Pennell
Journal: Med J Aust Date: 2019-07-14 Impact factor: 7.738

Review 4. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.

Authors: Charles I Okwundu; Bosede B Afolabi
Journal: Cochrane Database Syst Rev Date: 2013-01-31

5. Fetomaternal hemorrhage during external cephalic version.

Authors: Marc Boucher; Gerald P Marquette; Jocelyne Varin; Josette Champagne; Emmanuel Bujold
Journal: Obstet Gynecol Date: 2008-07 Impact factor: 7.661

6. Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.

Authors: Rebecca M Turner; Myfanwy Lloyd-Jones; Dilly O C Anumba; Gordon C S Smith; David J Spiegelhalter; Hazel Squires; John W Stevens; Michael J Sweeting; Stanislaw J Urbaniak; Robert Webster; Simon G Thompson
Journal: PLoS One Date: 2012-02-03 Impact factor: 3.240

7. Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review.

Authors: Britta Runkel; Gregor Bein; Wiebke Sieben; Dorothea Sow; Stephanie Polus; Daniel Fleer
Journal: BMC Pregnancy Childbirth Date: 2020-02-07 Impact factor: 3.007

8. Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.

Authors: Xiaohui Xie; Qiurong Fu; Ziwei Bao; Yi Zhang; Dan Zhou
Journal: PLoS One Date: 2020-03-12 Impact factor: 3.240

Review 9. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.

Authors: Rosemary D McBain; Caroline A Crowther; Philippa Middleton
Journal: Cochrane Database Syst Rev Date: 2015-09-03

1 in total

1. Evaluation of prophylactic polyclonal anti-D antibodies: Differences in Fc-glycosylation in commercial products.

Authors: Filippo Mori; Alfonso Salvatore; Ester Ascione; Raffaele Di Marzo; Bernard Fox
Journal: Vox Sang Date: 2021-10-26 Impact factor: 2.996

1 in total